Shopping Cart
- Remove All
Your shopping cart is currently empty
CGP-74514 (Compound 13) is a highly selective cyclin-dependent kinase 1 (CDK1) inhibitor (IC50=25 nM). This compound inhibits CDK1/cyclin B complex activity, resulting in G2/M phase cell cycle arrest and induction of tumor cell apoptosis, demonstrating promising applications in bladder cancer research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $90 | In Stock | |
| 5 mg | $222 | In Stock | |
| 10 mg | $355 | In Stock | |
| 25 mg | $645 | In Stock | |
| 50 mg | $969 | In Stock |
| Description | CGP-74514 (Compound 13) is a highly selective cyclin-dependent kinase 1 (CDK1) inhibitor (IC50=25 nM). This compound inhibits CDK1/cyclin B complex activity, resulting in G2/M phase cell cycle arrest and induction of tumor cell apoptosis, demonstrating promising applications in bladder cancer research. |
| Targets&IC50 | CDK1-CyclinB1:25 nM |
| Synonyms | CGP74514 |
| Molecular Weight | 385.89 |
| Formula | C19H24ClN7 |
| Cas No. | 190653-73-7 |
| Smiles | N(C1=C2C(N(CC)C=N2)=NC(N[C@@H]3[C@H](N)CCCC3)=N1)C4=CC(Cl)=CC=C4 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.